12
Prospects for cell-based therapies for ILD Tushar Desai, MD, MPH Stanford Medical School Division of Pulmonary, Department of Internal Medicine Institute for Stem Cell Biology and Regenerative Medicine

Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

Prospects for cell-based therapies for ILD

Tushar Desai, MD, MPH

Stanford Medical School

Division of Pulmonary, Department of Internal Medicine

Institute for Stem Cell Biology and Regenerative Medicine

Page 2: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

• Pluripotent stem cells:

– Can generate cells of all types for any tissue (embryonic)

– Can now be made from any cell from an adult person (induced)

• Adult stem cells:

– Restricted to generating cell types for a specific tissue throughout life (normal adult physiology)

– Dysfunction can result in diseases of aging (lose activity) or cancer (overactive)

• Adult progenitor cells:

– Like adult stem cells but more limited capacity for making new cells

– Dysfunction can result in cancer (e.g., leukemia)

Stem cells produce new cells

Page 3: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

• Blood stem cell failure (myelofibrosis) anemia

• Blood progenitor cell ‘overactivity’ leukemias

• ‘stem cell transplants’ = blood stem cell transplants

• Mainstay of modern medicine

• Leukemia: purify patient’s own stem cells from blood, give chemotherapy to kill diseased progenitor and cancer cells, then infuse back blood stem cells

• Sickle cell anemia: collect blood stem cells from suitable donor, give chemotherapy to kill patient’s stem cells, then transfuse donor blood stem cells– ** Immune suppression to prevent immune cells generated by donor stem

cells from attacking patient tissues!

Stem cell diseases

Page 4: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

Donor blood stem cell transplant

+Immunosuppression

Page 5: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

• Immune system– Recognizes ‘non-self’ cells and attacks them

• Re-transplanting your own stem cells:– Ideal because no need to suppress your own immune response

– Sickle cell anemia purify patient stem cells, use gene-editing to correct mutation in DNA, use chemotherapy to kill residual patient stem cells, then transfuse in “corrected” stem cells

• Transplanting in donor stem cells from another person:– Blood stem cells: Suppress foreign immune cells generated by donor blood stem

cells from attacking you!

– Non-blood stem cells: Immune suppression needed to prevent your own immune cells from killing the donor cells (but no worry about donor cells attacking you)

Self versus Other

Page 6: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

Lung stem cells

Bronchial tube

Tubes forbringing airin and out

Sacs forexchangingOxygen and

Carbon dioxide

Page 7: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

Two types of cells in the air sacs

#1 Very thin barrier

#2 Detergent

Blood flow

Oxygen

C02

Page 8: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

• The good:

– Lung is easy to access (by bronchoscopy)

– Disease is very active, so even halting progression may be very helpful

– Stem cells could reduce severity of “flares”

• The bad:

– How to get rid of defective stem cells without making patients sick?

• The unknown:

– After engraftment, will they remain healthy and active?

– Which is more feasible, adult versus pluripotent derived cells and self versus other?

IPF may be a stem cell disease!

Page 9: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

Human lung stem cells grown in the lab

Human Lung Lobe ~1x1 mm

Peripheral FragmentsSubmerged

3D culture

Dissociation

~1cmExtracellular Matrix

Media

Salahudeen et al, Nature (in revision)

Page 10: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

Correcting cystic fibrosis airway stem cells for re-

transplantation

Airway stem cells

Page 11: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

Cells from an IPF patient’s lungs grown in lab!

Day 2 Day 5 Day 8

Page 12: Prospects for cell-based therapies for ILD · 2020-05-13 · • ‘stem cell transplants’ = blood stem cell transplants • Mainstay of modern medicine • Leukemia: purify patient’s

Summary

• IPF may be a bona fide lung stem cell disease

• Hopefully coming down the pike!

• The best source of stem cells (pluripotent versus adult) is not clear

• Researchers are developing ways to collect and expand lung stem cells for transplantation